0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infectious Disease Diagnostics Testing Market Research Report 2022
Published Date: July 2022
|
Report Code: QYRE-Othe-2O272
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Infectious Disease Diagnostics Testing Market Size Status and Forecast 2021 2027

Global Infectious Disease Diagnostics Testing Market Research Report 2022

Code: QYRE-Othe-2O272
Report
July 2022
96 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Market Analysis and Insights: Global Infectious Disease Diagnostics Testing Market
In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.

The global Infectious Disease Diagnostics Testing market size is projected to reach US$ 21090 million by 2028, from US$ 16500 million in 2021, at a CAGR of 3.5% during 2022-2028.

Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Disease Diagnostics Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Disease Diagnostics Testing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Disease Diagnostics Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Disease Diagnostics Testing market.
Global Infectious Disease Diagnostics Testing Scope and Market Size
Infectious Disease Diagnostics Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Infectious Disease Diagnostics Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Molecular Diagnostic Test
POC Infectious Disease Diagnostics Test

Segment by Application

Hospital
Academics Research
Others

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Abbott
bioMérieux
Diasorin
Roche Diagnostic
Beckman Coulter
Becton, Dickinson and Company
Bio-Rad Laboratories
Cavidi
Cepheid
Corgenix
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
EUROIMMUN
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Molecular Diagnostic Test
1.2.3 POC Infectious Disease Diagnostics Test
1.3 Market by Application
1.3.1 Global Infectious Disease Diagnostics Testing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Academics Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Diagnostics Testing Market Perspective (2017-2028)
2.2 Infectious Disease Diagnostics Testing Growth Trends by Region
2.2.1 Infectious Disease Diagnostics Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Infectious Disease Diagnostics Testing Historic Market Size by Region (2017-2022)
2.2.3 Infectious Disease Diagnostics Testing Forecasted Market Size by Region (2023-2028)
2.3 Infectious Disease Diagnostics Testing Market Dynamics
2.3.1 Infectious Disease Diagnostics Testing Industry Trends
2.3.2 Infectious Disease Diagnostics Testing Market Drivers
2.3.3 Infectious Disease Diagnostics Testing Market Challenges
2.3.4 Infectious Disease Diagnostics Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Diagnostics Testing Players by Revenue
3.1.1 Global Top Infectious Disease Diagnostics Testing Players by Revenue (2017-2022)
3.1.2 Global Infectious Disease Diagnostics Testing Revenue Market Share by Players (2017-2022)
3.2 Global Infectious Disease Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Diagnostics Testing Revenue
3.4 Global Infectious Disease Diagnostics Testing Market Concentration Ratio
3.4.1 Global Infectious Disease Diagnostics Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Diagnostics Testing Revenue in 2021
3.5 Infectious Disease Diagnostics Testing Key Players Head office and Area Served
3.6 Key Players Infectious Disease Diagnostics Testing Product Solution and Service
3.7 Date of Enter into Infectious Disease Diagnostics Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Diagnostics Testing Breakdown Data by Type
4.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Type (2017-2022)
4.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2023-2028)
5 Infectious Disease Diagnostics Testing Breakdown Data by Application
5.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Application (2017-2022)
5.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Infectious Disease Diagnostics Testing Market Size (2017-2028)
6.2 North America Infectious Disease Diagnostics Testing Market Size by Country (2017-2022)
6.3 North America Infectious Disease Diagnostics Testing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Infectious Disease Diagnostics Testing Market Size (2017-2028)
7.2 Europe Infectious Disease Diagnostics Testing Market Size by Country (2017-2022)
7.3 Europe Infectious Disease Diagnostics Testing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Diagnostics Testing Market Size (2017-2028)
8.2 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Country (2017-2022)
8.3 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Infectious Disease Diagnostics Testing Market Size (2017-2028)
9.2 Latin America Infectious Disease Diagnostics Testing Market Size by Country (2017-2022)
9.3 Latin America Infectious Disease Diagnostics Testing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Diagnostics Testing Market Size (2017-2028)
10.2 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2017-2022)
10.3 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Infectious Disease Diagnostics Testing Introduction
11.1.4 Abbott Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.1.5 Abbott Recent Development
11.2 bioMérieux
11.2.1 bioMérieux Company Detail
11.2.2 bioMérieux Business Overview
11.2.3 bioMérieux Infectious Disease Diagnostics Testing Introduction
11.2.4 bioMérieux Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.2.5 bioMérieux Recent Development
11.3 Diasorin
11.3.1 Diasorin Company Detail
11.3.2 Diasorin Business Overview
11.3.3 Diasorin Infectious Disease Diagnostics Testing Introduction
11.3.4 Diasorin Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.3.5 Diasorin Recent Development
11.4 Roche Diagnostic
11.4.1 Roche Diagnostic Company Detail
11.4.2 Roche Diagnostic Business Overview
11.4.3 Roche Diagnostic Infectious Disease Diagnostics Testing Introduction
11.4.4 Roche Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.4.5 Roche Diagnostic Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Detail
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Infectious Disease Diagnostics Testing Introduction
11.5.4 Beckman Coulter Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.5.5 Beckman Coulter Recent Development
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Company Detail
11.6.2 Becton, Dickinson and Company Business Overview
11.6.3 Becton, Dickinson and Company Infectious Disease Diagnostics Testing Introduction
11.6.4 Becton, Dickinson and Company Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.6.5 Becton, Dickinson and Company Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Infectious Disease Diagnostics Testing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Cavidi
11.8.1 Cavidi Company Detail
11.8.2 Cavidi Business Overview
11.8.3 Cavidi Infectious Disease Diagnostics Testing Introduction
11.8.4 Cavidi Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.8.5 Cavidi Recent Development
11.9 Cepheid
11.9.1 Cepheid Company Detail
11.9.2 Cepheid Business Overview
11.9.3 Cepheid Infectious Disease Diagnostics Testing Introduction
11.9.4 Cepheid Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.9.5 Cepheid Recent Development
11.10 Corgenix
11.10.1 Corgenix Company Detail
11.10.2 Corgenix Business Overview
11.10.3 Corgenix Infectious Disease Diagnostics Testing Introduction
11.10.4 Corgenix Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.10.5 Corgenix Recent Development
11.11 Diaxonhit
11.11.1 Diaxonhit Company Detail
11.11.2 Diaxonhit Business Overview
11.11.3 Diaxonhit Infectious Disease Diagnostics Testing Introduction
11.11.4 Diaxonhit Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.11.5 Diaxonhit Recent Development
11.12 Eiken Chemical
11.12.1 Eiken Chemical Company Detail
11.12.2 Eiken Chemical Business Overview
11.12.3 Eiken Chemical Infectious Disease Diagnostics Testing Introduction
11.12.4 Eiken Chemical Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.12.5 Eiken Chemical Recent Development
11.13 EMD Millipore
11.13.1 EMD Millipore Company Detail
11.13.2 EMD Millipore Business Overview
11.13.3 EMD Millipore Infectious Disease Diagnostics Testing Introduction
11.13.4 EMD Millipore Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.13.5 EMD Millipore Recent Development
11.14 Epitope Diagnostic
11.14.1 Epitope Diagnostic Company Detail
11.14.2 Epitope Diagnostic Business Overview
11.14.3 Epitope Diagnostic Infectious Disease Diagnostics Testing Introduction
11.14.4 Epitope Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.14.5 Epitope Diagnostic Recent Development
11.15 EUROIMMUN
11.15.1 EUROIMMUN Company Detail
11.15.2 EUROIMMUN Business Overview
11.15.3 EUROIMMUN Infectious Disease Diagnostics Testing Introduction
11.15.4 EUROIMMUN Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.15.5 EUROIMMUN Recent Development
11.16 Gold Standard Diagnostics
11.16.1 Gold Standard Diagnostics Company Detail
11.16.2 Gold Standard Diagnostics Business Overview
11.16.3 Gold Standard Diagnostics Infectious Disease Diagnostics Testing Introduction
11.16.4 Gold Standard Diagnostics Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.16.5 Gold Standard Diagnostics Recent Development
11.17 Hologic
11.17.1 Hologic Company Detail
11.17.2 Hologic Business Overview
11.17.3 Hologic Infectious Disease Diagnostics Testing Introduction
11.17.4 Hologic Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.17.5 Hologic Recent Development
11.18 Immunetics
11.18.1 Immunetics Company Detail
11.18.2 Immunetics Business Overview
11.18.3 Immunetics Infectious Disease Diagnostics Testing Introduction
11.18.4 Immunetics Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.18.5 Immunetics Recent Development
11.19 InBios International
11.19.1 InBios International Company Detail
11.19.2 InBios International Business Overview
11.19.3 InBios International Infectious Disease Diagnostics Testing Introduction
11.19.4 InBios International Revenue in Infectious Disease Diagnostics Testing Business (2017-2022)
11.19.5 InBios International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Molecular Diagnostic Test
    Table 3. Key Players of POC Infectious Disease Diagnostics Test
    Table 4. Global Infectious Disease Diagnostics Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Infectious Disease Diagnostics Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Infectious Disease Diagnostics Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Infectious Disease Diagnostics Testing Market Share by Region (2017-2022)
    Table 8. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Infectious Disease Diagnostics Testing Market Share by Region (2023-2028)
    Table 10. Infectious Disease Diagnostics Testing Market Trends
    Table 11. Infectious Disease Diagnostics Testing Market Drivers
    Table 12. Infectious Disease Diagnostics Testing Market Challenges
    Table 13. Infectious Disease Diagnostics Testing Market Restraints
    Table 14. Global Infectious Disease Diagnostics Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Infectious Disease Diagnostics Testing Market Share by Players (2017-2022)
    Table 16. Global Top Infectious Disease Diagnostics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics Testing as of 2021)
    Table 17. Ranking of Global Top Infectious Disease Diagnostics Testing Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Infectious Disease Diagnostics Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Infectious Disease Diagnostics Testing Product Solution and Service
    Table 21. Date of Enter into Infectious Disease Diagnostics Testing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Infectious Disease Diagnostics Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2017-2022)
    Table 25. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2023-2028)
    Table 27. Global Infectious Disease Diagnostics Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Infectious Disease Diagnostics Testing Revenue Market Share by Application (2017-2022)
    Table 29. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Infectious Disease Diagnostics Testing Revenue Market Share by Application (2023-2028)
    Table 31. North America Infectious Disease Diagnostics Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Infectious Disease Diagnostics Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Infectious Disease Diagnostics Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Infectious Disease Diagnostics Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Infectious Disease Diagnostics Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Infectious Disease Diagnostics Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Abbott Company Detail
    Table 42. Abbott Business Overview
    Table 43. Abbott Infectious Disease Diagnostics Testing Product
    Table 44. Abbott Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 45. Abbott Recent Development
    Table 46. bioMérieux Company Detail
    Table 47. bioMérieux Business Overview
    Table 48. bioMérieux Infectious Disease Diagnostics Testing Product
    Table 49. bioMérieux Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 50. bioMérieux Recent Development
    Table 51. Diasorin Company Detail
    Table 52. Diasorin Business Overview
    Table 53. Diasorin Infectious Disease Diagnostics Testing Product
    Table 54. Diasorin Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 55. Diasorin Recent Development
    Table 56. Roche Diagnostic Company Detail
    Table 57. Roche Diagnostic Business Overview
    Table 58. Roche Diagnostic Infectious Disease Diagnostics Testing Product
    Table 59. Roche Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 60. Roche Diagnostic Recent Development
    Table 61. Beckman Coulter Company Detail
    Table 62. Beckman Coulter Business Overview
    Table 63. Beckman Coulter Infectious Disease Diagnostics Testing Product
    Table 64. Beckman Coulter Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 65. Beckman Coulter Recent Development
    Table 66. Becton, Dickinson and Company Company Detail
    Table 67. Becton, Dickinson and Company Business Overview
    Table 68. Becton, Dickinson and Company Infectious Disease Diagnostics Testing Product
    Table 69. Becton, Dickinson and Company Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 70. Becton, Dickinson and Company Recent Development
    Table 71. Bio-Rad Laboratories Company Detail
    Table 72. Bio-Rad Laboratories Business Overview
    Table 73. Bio-Rad Laboratories Infectious Disease Diagnostics Testing Product
    Table 74. Bio-Rad Laboratories Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 75. Bio-Rad Laboratories Recent Development
    Table 76. Cavidi Company Detail
    Table 77. Cavidi Business Overview
    Table 78. Cavidi Infectious Disease Diagnostics Testing Product
    Table 79. Cavidi Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 80. Cavidi Recent Development
    Table 81. Cepheid Company Detail
    Table 82. Cepheid Business Overview
    Table 83. Cepheid Infectious Disease Diagnostics Testing Product
    Table 84. Cepheid Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 85. Cepheid Recent Development
    Table 86. Corgenix Company Detail
    Table 87. Corgenix Business Overview
    Table 88. Corgenix Infectious Disease Diagnostics Testing Product
    Table 89. Corgenix Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 90. Corgenix Recent Development
    Table 91. Diaxonhit Company Detail
    Table 92. Diaxonhit Business Overview
    Table 93. Diaxonhit Infectious Disease Diagnostics TestingProduct
    Table 94. Diaxonhit Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 95. Diaxonhit Recent Development
    Table 96. Eiken Chemical Company Detail
    Table 97. Eiken Chemical Business Overview
    Table 98. Eiken Chemical Infectious Disease Diagnostics TestingProduct
    Table 99. Eiken Chemical Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 100. Eiken Chemical Recent Development
    Table 101. EMD Millipore Company Detail
    Table 102. EMD Millipore Business Overview
    Table 103. EMD Millipore Infectious Disease Diagnostics TestingProduct
    Table 104. EMD Millipore Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 105. EMD Millipore Recent Development
    Table 106. Epitope Diagnostic Company Detail
    Table 107. Epitope Diagnostic Business Overview
    Table 108. Epitope Diagnostic Infectious Disease Diagnostics TestingProduct
    Table 109. Epitope Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 110. Epitope Diagnostic Recent Development
    Table 111. EUROIMMUN Company Detail
    Table 112. EUROIMMUN Business Overview
    Table 113. EUROIMMUN Infectious Disease Diagnostics TestingProduct
    Table 114. EUROIMMUN Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 115. EUROIMMUN Recent Development
    Table 116. Gold Standard Diagnostics Company Detail
    Table 117. Gold Standard Diagnostics Business Overview
    Table 118. Gold Standard Diagnostics Infectious Disease Diagnostics TestingProduct
    Table 119. Gold Standard Diagnostics Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 120. Gold Standard Diagnostics Recent Development
    Table 121. Hologic Company Detail
    Table 122. Hologic Business Overview
    Table 123. Hologic Infectious Disease Diagnostics TestingProduct
    Table 124. Hologic Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 125. Hologic Recent Development
    Table 126. Immunetics Company Detail
    Table 127. Immunetics Business Overview
    Table 128. Immunetics Infectious Disease Diagnostics TestingProduct
    Table 129. Immunetics Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 130. Immunetics Recent Development
    Table 131. InBios International Company Detail
    Table 132. InBios International Business Overview
    Table 133. InBios International Infectious Disease Diagnostics TestingProduct
    Table 134. InBios International Revenue in Infectious Disease Diagnostics Testing Business (2017-2022) & (US$ Million)
    Table 135. InBios International Recent Development
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Infectious Disease Diagnostics Testing Market Share by Type: 2021 VS 2028
    Figure 2. Molecular Diagnostic Test Features
    Figure 3. POC Infectious Disease Diagnostics Test Features
    Figure 4. Global Infectious Disease Diagnostics Testing Market Share by Application in 2021 & 2028
    Figure 5. Hospital Case Studies
    Figure 6. Academics Research Case Studies
    Figure 7. Others Case Studies
    Figure 8. Infectious Disease Diagnostics Testing Report Years Considered
    Figure 9. Global Infectious Disease Diagnostics Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Infectious Disease Diagnostics Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Infectious Disease Diagnostics Testing Market Share by Region: 2021 VS 2028
    Figure 12. Global Infectious Disease Diagnostics Testing Market Share by Players in 2021
    Figure 13. Global Top Infectious Disease Diagnostics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics Testing as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Infectious Disease Diagnostics Testing Revenue in 2021
    Figure 15. North America Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Infectious Disease Diagnostics Testing Market Share by Country (2017-2028)
    Figure 17. United States Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Infectious Disease Diagnostics Testing Market Share by Country (2017-2028)
    Figure 21. Germany Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Infectious Disease Diagnostics Testing Market Share by Region (2017-2028)
    Figure 29. China Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Infectious Disease Diagnostics Testing Market Share by Country (2017-2028)
    Figure 37. Mexico Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Infectious Disease Diagnostics Testing Market Share by Country (2017-2028)
    Figure 41. Turkey Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Infectious Disease Diagnostics Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Abbott Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 44. bioMérieux Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 45. Diasorin Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 46. Roche Diagnostic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 47. Beckman Coulter Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 48. Becton, Dickinson and Company Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 50. Cavidi Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 51. Cepheid Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 52. Corgenix Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 53. Diaxonhit Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 54. Eiken Chemical Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 55. EMD Millipore Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 56. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 57. EUROIMMUN Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 58. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 59. Hologic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 60. Immunetics Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 61. InBios International Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI